Drug delivery device

ChangeBridge: EPO Bulletin - Medical Devices (A61M)

Published March 25th, 2026

Detected April 1st, 2026

Summary

The European Patent Office published European Patent EP3595743A1 for a drug delivery device filed by Sanofi-Aventis Deutschland GmbH. The patent application covers injection mechanisms and drug delivery technology. Publication date was March 25, 2026.

View original document View source feed page

What changed

EPO published European Patent EP3595743A1 titled 'Drug delivery device' with applicants Sanofi-Aventis Deutschland GmbH and inventors Dasbach, Schader, Kneip, Rau, and Nober. The patent is classified under IPC A61M 5/20 and designates all major European contracting states including DE, FR, GB, IT, ES, NL, and others.

This is an informational patent publication notice with no compliance obligations. Manufacturers and pharmaceutical companies developing similar drug delivery technologies should review the patent for freedom-to-operate considerations and potential licensing implications.

Source document (simplified)

← EPO Patent Bulletin

DRUG DELIVERY DEVICE

Publication EP3595743A1 Kind: A1 Mar 25, 2026

Applicants

Sanofi-Aventis Deutschland GmbH

Inventors

DASBACH, Uwe, SCHADER, Marc, KNEIP, Michael, RAU, Matthias, NOBER, Peter

IPC Classifications

A61M 5/20 20060101AFI20180921BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →